AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-242502469/novo-nordisk-interim-financial.html" title="Facts and information about Novo Nordisk: Interim financial report for the period 1 Jan 2010 to 30 Sep 2010: Diabetes Care sales development.">Novo Nordisk: Interim financial report for the period 1 Jan 2010 to 30 Sep 2010: Diabetes Care sales development.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Novo Nordisk: Interim financial report for the period 1 Jan 2010 to 30 Sep 2010: Diabetes Care sales development.
For the first nine months of its fiscal 2010 (period ends 30 Sep 2010), Novo Nordisk A/S has reported sales of Diabetes Care products of DKR 33.4 bn (+20% on the same period of its fiscal 2009), of which: modern insulins accounted for DKR 19.4 bn (+24%), human insulins DKR 8835 M (+2%), protein-related products DKR 1653 M (+13%), …
Related articles from newspapers, magazines, journals, and more
-
- Novo Nordisk is a diabetes care leader.
-
News wire article from: Chemical Business Newsbase
July 24, 2008
700+ words
-
- Novo Nordisk to expand US diabetes care sales force to 1,900 from 1,200.
-
News wire article from: Europe Intelligence Wire
November 30, 2006
700+ words
-
- Novo Nordisk: Financial statement for 2010: Diabetes Care segment.
-
News wire article from: Chemical Business Newsbase
February 2, 2011
700+ words
-
- Press Release: Novo Nordisk and Rite Aid join forces to improve diabetes care.
-
News wire article from: Chemical Business Newsbase
March 28, 2002
700+ words
-
- Novo Nordisk Pharma to strengthen business in diabetes care field.
-
News wire article from: Chemical Business Newsbase
March 30, 2006
700+ words
